Tokyo, July 8 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058393) titled 'Association between heart failure pharmacotherapy and nutritional status' on July 7.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd.
Condition:
Condition - Heart Failure (HF)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To evaluate the first worsening of nutritional status after HF hospitalization (HHF), stratified by the number of HF drugs prescribed during HHF.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 18
years-old
= 18 years who are diagnosed with HF during hospitalization within the Study Period
(2) Patients discharged on or after Index Date.
(3) Patients with CONUT, GNRI, or PNI data during the Baseline Period and after Baseline Period.
(4) Patients who have medical records in the Medical Data Vision Co., Ltd. (MDV) database for one year or more before the Index Date.
Key exclusion criteria - (1) Patients who have ICD-10 codes identifying HF before Index Date.
(2) Patients who underwent cardiac pacemaker, implantable cardioverter-defibrillator implantation, cardiac resynchronization therapy, catheter ablation, coronary artery bypass graft surgery, percutaneous coronary intervention, surgical or percutaneous intervention for heart valve disease in Look Back Period.
(3) Patients who were hospitalized for acute myocardial infarction in Look Back Period.
Target Size - 300000
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 06 Month 11 Day
Anticipated trial start date - 2025 Year 12 Month 19 Day
Last follow-up date - 2025 Year 12 Month 19 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066718
Disclaimer: Curated by HT Syndication.
